University of Washington: Ovarian Neoplasms trials

The registry lists 15 Ovarian Neoplasms studies with University of Washington as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 6Phase 2 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of RecurrenceRecruitingNCT07495124Phase 2
• Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES StudyRecruitingNCT06295965
• The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsTerminatedNCT03641287Not applicableResults posted
• Lavage of the Uterine Cavity for Diagnosis of Ovarian CancerTerminatedNCT03606486Not applicableResults posted
• IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing SurgeryTerminatedNCT03029611Phase 2Results posted
• Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving TrastuzumabCompletedNCT00194714Phase 1/2Results posted
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04673448Phase 1
• Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT04387227Phase 2
• Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype FamiliesCompletedNCT03119285
• Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse CaregiversCompletedNCT02401321Not applicable
• Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive StudyCompletedNCT01544049
• Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian CancerCompletedNCT01322802Phase 1
• Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1
• Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerCompletedNCT00436254Phase 1
• Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineCompletedNCT00228358Phase 1